• Tue news: Pfizer explores sale of hospital drugs unit. FDA declines full approval of Ocaliva. AZ better than expected Q3 results. Pfizer, Lilly telehealth platforms draw scrutiny. 23andMe cutting lays off 40%. See more on our front page

FDA puts Curis' leukemia trial on partial hold after patient death spurs review of...

Quote
cafead

cafead

Administrator
Staff member
  • cafead   Apr 04, 2022 at 10:53: AM
via The list of biotechs under clinical hold keeps getting longer. Curis is the latest company to join the list, with the FDA slapping a partial hold on a phase 1/2a leukemia study while it gathers information about the death of a patient.

article source
 




Top Bottom
Back
Quote